Related references
Note: Only part of the references are listed.Glucarpidase (carboxypeptidase G2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy
Stefan Schwartz et al.
ONCOLOGIST (2007)
Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays
K Fotoohi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Pharmacogenetics of disease-modifying anti-rheumatic drugs
E Tanaka et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
Contribution of common polymorphisms in reduced folate carrier and γ-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis
T Dervieux et al.
PHARMACOGENETICS (2004)
Use of methotrexate in juvenile idiopathic arthritis
AV Ramanan et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Rational use of new and existing disease-modifying agents in rheumatoid arthritis
JM Kremer
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
